Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIFABUTIN Cause Multiple organ dysfunction syndrome? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Multiple organ dysfunction syndrome have been filed in association with RIFABUTIN (Rifabutin). This represents 0.6% of all adverse event reports for RIFABUTIN.

10
Reports of Multiple organ dysfunction syndrome with RIFABUTIN
0.6%
of all RIFABUTIN reports
10
Deaths
10
Hospitalizations

How Dangerous Is Multiple organ dysfunction syndrome From RIFABUTIN?

Of the 10 reports, 10 (100.0%) resulted in death, 10 (100.0%) required hospitalization.

Is Multiple organ dysfunction syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIFABUTIN. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does RIFABUTIN Cause?

Drug ineffective (171) Off label use (127) Drug resistance (123) Drug interaction (99) Drug intolerance (97) Pyrexia (95) Drug reaction with eosinophilia and systemic symptoms (81) Nausea (77) Neutropenia (77) Mycobacterium avium complex infection (76)

What Other Drugs Cause Multiple organ dysfunction syndrome?

TACROLIMUS (1,847) CYCLOPHOSPHAMIDE (1,597) MYCOPHENOLATE MOFETIL (1,566) PREDNISONE (1,525) DEXAMETHASONE (1,355) METHOTREXATE (1,317) METHYLPREDNISOLONE (1,278) RITUXIMAB (1,188) PREDNISOLONE (1,154) CYCLOSPORINE (933)

Which RIFABUTIN Alternatives Have Lower Multiple organ dysfunction syndrome Risk?

RIFABUTIN vs RIFAMPICIN RIFABUTIN vs RIFAMPIN RIFABUTIN vs RIFAMYCIN RIFABUTIN vs RIFAPENTINE RIFABUTIN vs RIFAXIMIN

Related Pages

RIFABUTIN Full Profile All Multiple organ dysfunction syndrome Reports All Drugs Causing Multiple organ dysfunction syndrome RIFABUTIN Demographics